Rabies control in South and Southeast Asia.
Identifieur interne : 004959 ( Main/Merge ); précédent : 004958; suivant : 004960Rabies control in South and Southeast Asia.
Auteurs : Henry Wilde [Thaïlande] ; Pakamatz Khawplod ; Thavatchai Khamoltham ; Thiravat Hemachudha ; Veera Tepsumethanon ; Boonlert Lumlerdacha ; Channarong Mitmoonpitak ; Visith SitprijaSource :
- Vaccine [ 0264-410X ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
- administration et posologie : Vaccins antirabiques.
- diagnostic : Rage (maladie).
- immunologie : Maladies des chiens, Virus de la rage.
- médecine vétérinaire : Rage (maladie).
- sang : Anticorps antiviraux.
- Animaux, Asie, Asie du Sud-Est, Chiens, Maladies des chiens, Rage (maladie).
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Rabies Vaccines.
- chemical , blood : Antibodies, Viral.
- geographic : Asia, Asia, Southeastern.
- diagnosis : Rabies.
- immunology : Dog Diseases, Rabies virus.
- prevention & control : Dog Diseases, Rabies.
- therapy : Rabies.
- veterinary : Rabies.
- Animals, Dogs.
Abstract
We have the knowledge and tools to eliminate the threat of canine rabies but this disease, nevertheless, remains a public health threat in many parts of the world. Lack of motivation by governments, cultural issues and inadequate funding remain barriers. This is amazing since the number of human rabies deaths worldwide is greater than that from polio, meningococcal meningitis, Japanese encephalitis, yellow fever, SARS, bird flue and other scourges that attract more attention. Safe and effective vaccines are now widely available. Reduced dose effective and less expensive post-exposure vaccination regimens have helped eliminate nerve tissue vaccines in Thailand, Philippines and Sri Lanka. India and Pakistan, the major users of dangerous nerve tissue derived Semple type vaccine, are now considering following suite. Immediate wound care and prompt use of a potent vaccine will save a majority of infected persons. Rabies immunoglobulin, injected into and around bite wounds, provides added safety for the severely exposed. The high cost of rabies immunoglobulin and tissue culture vaccines are remaining barriers, but new manufacturers and the use of intradermal vaccination schedules can reduce costs. Ultimately, it is the need to control rabies in dogs that must occupy most of our attention. The tools are available, but attitudes must change before they can be applied. There have been many new developments since publication of the last WHO rabies expert committee report in 1992 (new version in print)] and we will address those that have practical applicability.
DOI: 10.1016/j.vaccine.2005.01.030
PubMed: 15755612
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002852
- to stream PubMed, to step Curation: 002852
- to stream PubMed, to step Checkpoint: 002554
- to stream Ncbi, to step Merge: 000E22
- to stream Ncbi, to step Curation: 000E22
- to stream Ncbi, to step Checkpoint: 000E22
Links to Exploration step
pubmed:15755612Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rabies control in South and Southeast Asia.</title><author><name sortKey="Wilde, Henry" sort="Wilde, Henry" uniqKey="Wilde H" first="Henry" last="Wilde">Henry Wilde</name><affiliation wicri:level="1"><nlm:affiliation>Queen Saovabha Memorial Institute, Thai Red Cross Society, (WHO Collaborating Center) and Department of Medicine, King Chulalongkorn University Hospital, 1871 Rama IV Road, Bangkok 10330, Thailand. docwilde@loxinfo.co.th</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Queen Saovabha Memorial Institute, Thai Red Cross Society, (WHO Collaborating Center) and Department of Medicine, King Chulalongkorn University Hospital, 1871 Rama IV Road, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author><author><name sortKey="Khawplod, Pakamatz" sort="Khawplod, Pakamatz" uniqKey="Khawplod P" first="Pakamatz" last="Khawplod">Pakamatz Khawplod</name></author><author><name sortKey="Khamoltham, Thavatchai" sort="Khamoltham, Thavatchai" uniqKey="Khamoltham T" first="Thavatchai" last="Khamoltham">Thavatchai Khamoltham</name></author><author><name sortKey="Hemachudha, Thiravat" sort="Hemachudha, Thiravat" uniqKey="Hemachudha T" first="Thiravat" last="Hemachudha">Thiravat Hemachudha</name></author><author><name sortKey="Tepsumethanon, Veera" sort="Tepsumethanon, Veera" uniqKey="Tepsumethanon V" first="Veera" last="Tepsumethanon">Veera Tepsumethanon</name></author><author><name sortKey="Lumlerdacha, Boonlert" sort="Lumlerdacha, Boonlert" uniqKey="Lumlerdacha B" first="Boonlert" last="Lumlerdacha">Boonlert Lumlerdacha</name></author><author><name sortKey="Mitmoonpitak, Channarong" sort="Mitmoonpitak, Channarong" uniqKey="Mitmoonpitak C" first="Channarong" last="Mitmoonpitak">Channarong Mitmoonpitak</name></author><author><name sortKey="Sitprija, Visith" sort="Sitprija, Visith" uniqKey="Sitprija V" first="Visith" last="Sitprija">Visith Sitprija</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2005">2005</date><idno type="RBID">pubmed:15755612</idno><idno type="pmid">15755612</idno><idno type="doi">10.1016/j.vaccine.2005.01.030</idno><idno type="wicri:Area/PubMed/Corpus">002852</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002852</idno><idno type="wicri:Area/PubMed/Curation">002852</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002852</idno><idno type="wicri:Area/PubMed/Checkpoint">002554</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002554</idno><idno type="wicri:Area/Ncbi/Merge">000E22</idno><idno type="wicri:Area/Ncbi/Curation">000E22</idno><idno type="wicri:Area/Ncbi/Checkpoint">000E22</idno><idno type="wicri:doubleKey">0264-410X:2005:Wilde H:rabies:control:in</idno><idno type="wicri:Area/Main/Merge">004959</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Rabies control in South and Southeast Asia.</title><author><name sortKey="Wilde, Henry" sort="Wilde, Henry" uniqKey="Wilde H" first="Henry" last="Wilde">Henry Wilde</name><affiliation wicri:level="1"><nlm:affiliation>Queen Saovabha Memorial Institute, Thai Red Cross Society, (WHO Collaborating Center) and Department of Medicine, King Chulalongkorn University Hospital, 1871 Rama IV Road, Bangkok 10330, Thailand. docwilde@loxinfo.co.th</nlm:affiliation><country xml:lang="fr">Thaïlande</country><wicri:regionArea>Queen Saovabha Memorial Institute, Thai Red Cross Society, (WHO Collaborating Center) and Department of Medicine, King Chulalongkorn University Hospital, 1871 Rama IV Road, Bangkok 10330</wicri:regionArea><wicri:noRegion>Bangkok 10330</wicri:noRegion></affiliation></author><author><name sortKey="Khawplod, Pakamatz" sort="Khawplod, Pakamatz" uniqKey="Khawplod P" first="Pakamatz" last="Khawplod">Pakamatz Khawplod</name></author><author><name sortKey="Khamoltham, Thavatchai" sort="Khamoltham, Thavatchai" uniqKey="Khamoltham T" first="Thavatchai" last="Khamoltham">Thavatchai Khamoltham</name></author><author><name sortKey="Hemachudha, Thiravat" sort="Hemachudha, Thiravat" uniqKey="Hemachudha T" first="Thiravat" last="Hemachudha">Thiravat Hemachudha</name></author><author><name sortKey="Tepsumethanon, Veera" sort="Tepsumethanon, Veera" uniqKey="Tepsumethanon V" first="Veera" last="Tepsumethanon">Veera Tepsumethanon</name></author><author><name sortKey="Lumlerdacha, Boonlert" sort="Lumlerdacha, Boonlert" uniqKey="Lumlerdacha B" first="Boonlert" last="Lumlerdacha">Boonlert Lumlerdacha</name></author><author><name sortKey="Mitmoonpitak, Channarong" sort="Mitmoonpitak, Channarong" uniqKey="Mitmoonpitak C" first="Channarong" last="Mitmoonpitak">Channarong Mitmoonpitak</name></author><author><name sortKey="Sitprija, Visith" sort="Sitprija, Visith" uniqKey="Sitprija V" first="Visith" last="Sitprija">Visith Sitprija</name></author></analytic><series><title level="j">Vaccine</title><idno type="ISSN">0264-410X</idno><imprint><date when="2005" type="published">2005</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Antibodies, Viral (blood)</term><term>Asia</term><term>Asia, Southeastern</term><term>Dog Diseases (immunology)</term><term>Dog Diseases (prevention & control)</term><term>Dogs</term><term>Rabies (diagnosis)</term><term>Rabies (prevention & control)</term><term>Rabies (therapy)</term><term>Rabies (veterinary)</term><term>Rabies Vaccines (administration & dosage)</term><term>Rabies virus (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Anticorps antiviraux (sang)</term><term>Asie</term><term>Asie du Sud-Est</term><term>Chiens</term><term>Maladies des chiens ()</term><term>Maladies des chiens (immunologie)</term><term>Rage (maladie) ()</term><term>Rage (maladie) (diagnostic)</term><term>Rage (maladie) (médecine vétérinaire)</term><term>Vaccins antirabiques (administration et posologie)</term><term>Virus de la rage (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Rabies Vaccines</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Asia</term><term>Asia, Southeastern</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antirabiques</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Rabies</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Rage (maladie)</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Maladies des chiens</term><term>Virus de la rage</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Dog Diseases</term><term>Rabies virus</term></keywords><keywords scheme="MESH" qualifier="médecine vétérinaire" xml:lang="fr"><term>Rage (maladie)</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Dog Diseases</term><term>Rabies</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Anticorps antiviraux</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Rabies</term></keywords><keywords scheme="MESH" qualifier="veterinary" xml:lang="en"><term>Rabies</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Dogs</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Asie</term><term>Asie du Sud-Est</term><term>Chiens</term><term>Maladies des chiens</term><term>Rage (maladie)</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We have the knowledge and tools to eliminate the threat of canine rabies but this disease, nevertheless, remains a public health threat in many parts of the world. Lack of motivation by governments, cultural issues and inadequate funding remain barriers. This is amazing since the number of human rabies deaths worldwide is greater than that from polio, meningococcal meningitis, Japanese encephalitis, yellow fever, SARS, bird flue and other scourges that attract more attention. Safe and effective vaccines are now widely available. Reduced dose effective and less expensive post-exposure vaccination regimens have helped eliminate nerve tissue vaccines in Thailand, Philippines and Sri Lanka. India and Pakistan, the major users of dangerous nerve tissue derived Semple type vaccine, are now considering following suite. Immediate wound care and prompt use of a potent vaccine will save a majority of infected persons. Rabies immunoglobulin, injected into and around bite wounds, provides added safety for the severely exposed. The high cost of rabies immunoglobulin and tissue culture vaccines are remaining barriers, but new manufacturers and the use of intradermal vaccination schedules can reduce costs. Ultimately, it is the need to control rabies in dogs that must occupy most of our attention. The tools are available, but attitudes must change before they can be applied. There have been many new developments since publication of the last WHO rabies expert committee report in 1992 (new version in print)] and we will address those that have practical applicability.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004959 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 004959 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:15755612
|texte= Rabies control in South and Southeast Asia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:15755612" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |